Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors.
about
Safe handling of oral antineoplastic medications: focus on targeted therapeutics in the home settingEvaluation of high-risk clinicopathological indicators in gastrointestinal stromal tumors for prognosis and imatinib treatment outcome.Adjuvant treatment of GIST: patient selection and treatment strategies.Adjuvant therapy for high-risk gastrointestinal stromal tumour: considerations for optimal management.New fronts in the adjuvant treatment of GIST.Duodenal gastrointestinal stromal tumors: clinicopathological characteristics, surgery, and long-term outcome.Treatment and Prognoses in Patients With Primary Gastrointestinal Stromal Tumors ≥10 cm: A Single-Institution Experience in China.Short- and Long-Term Outcomes of Laparoscopic Versus Open Resection for Gastric Gastrointestinal Stromal Tumors: A Propensity Score-Matching Analysis.Optimizing tyrosine kinase inhibitor therapy in gastrointestinal stromal tumors: exploring the benefits of continuous kinase suppression.Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor.Laparoscopic resection of gastrointestinal stromal tumors: Does laparoscopic surgery provide an adequate oncologic resection?Primary Extra-gastrointestinal Stromal Tumor of Retroperitoneum.Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.Prognostic factors of primary gastrointestinal stromal tumors: a cohort study based on high-volume centers.[Translational research and diagnosis in GIST].
P2860
Q23923997-F3B81186-0A17-4C07-9EEC-4112F61EF55EQ33756596-4821DD51-C66C-4475-8BF0-DBDBAA7A04AAQ34270274-604E6B88-FA1C-4736-AF4D-70C10091D954Q34300784-E7AD5173-EEDF-4036-8022-23170D407D02Q34655266-86F06986-E6AE-449D-BA8B-F49F74EEB41AQ35746953-8BD1D750-9CEA-45D0-B9BF-7AFA018B57A3Q36196622-D91FA3AE-D06A-440C-84A8-27EBF800D753Q36822275-506A9DF8-9855-4BCE-A15E-B86C8AE893D7Q37301465-6E552B84-1089-442A-BCB7-0C426F1B9AADQ39394480-5B6E3A2E-7048-49C8-B754-48BD9A976674Q41926067-C0379F73-E382-45B3-89A7-4B0195DBCCBEQ42065463-47002118-FB78-448A-9528-65FD0785A78AQ50913835-08DCC203-FB85-4652-8559-A5ADF53219E0Q52653166-245280BD-1929-448A-8E82-A2F4A48CA3E6Q54484634-164857E3-C405-427D-B3C1-9A9D4D3CF9CE
P2860
Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adjuvant and neoadjuvant imati ...... strointestinal stromal tumors.
@en
Adjuvant and neoadjuvant imati ...... strointestinal stromal tumors.
@nl
type
label
Adjuvant and neoadjuvant imati ...... strointestinal stromal tumors.
@en
Adjuvant and neoadjuvant imati ...... strointestinal stromal tumors.
@nl
prefLabel
Adjuvant and neoadjuvant imati ...... strointestinal stromal tumors.
@en
Adjuvant and neoadjuvant imati ...... strointestinal stromal tumors.
@nl
P2860
P356
P1476
Adjuvant and neoadjuvant imati ...... strointestinal stromal tumors.
@en
P2093
Burton L Eisenberg
Jonathan C Trent
P2860
P304
P356
10.1002/IJC.26234
P577
2011-12-01T00:00:00Z